Provided by Tiger Trade Technology Pte. Ltd.

Corvus Pharmaceuticals

13.94
-0.2250-1.59%
Volume:119.29K
Turnover:1.65M
Market Cap:1.17B
PE:-22.29
High:14.16
Open:14.09
Low:13.71
Close:14.16
52wk High:26.95
52wk Low:5.58
Shares:83.77M
Float Shares:74.12M
Volume Ratio:0.63
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6252
EPS(LYR):-0.5320
ROE:-35.43%
ROA:-21.66%
PB:5.18
PE(LYR):-26.19

Loading ...

Does Peer-Reviewed Phase 1 Soquelitinib Data Reshape The Bull Case For Corvus Pharmaceuticals (CRVS)?

Simply Wall St.
·
Aug 29

Corvus Publishes Final Phase 1/1b Soquelitinib Data in Blood Supporting Phase 3 Relapsed/refractory PTCL Trial

Reuters
·
Aug 27

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1B T Cell Lymphoma Trial

THOMSON REUTERS
·
Aug 27

Barclays Keeps Their Buy Rating on Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
Aug 07

Corvus Publishes Corporate Presentation Highlighting Soquelitinib ITK Inhibitor Pipeline in Immune Disease and T-Cell Malignancies

Reuters
·
Aug 07

Corvus Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Corvus Pharma Q2 EPS $(0.19) Misses $(0.17) Estimate

Benzinga Earnings
·
Aug 07

Corvus Pharmaceuticals Schedules Q2 Financial Results Conference Call and Webcast

Reuters
·
Jul 31

Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026

THOMSON REUTERS
·
Jul 31

Corvus Pharmaceuticals Director Ian T. Clark Resigns from Board

Reuters
·
Jul 23

Analysts Are Bullish on Top Healthcare Stocks: Corvus Pharmaceuticals (CRVS), IN8bio (INAB)

TIPRANKS
·
Jul 06

Top Corvus Pharmaceuticals Insider Makes Bold New Bet on the Company’s Future

TIPRANKS
·
Jun 16

Corvus Pharma director David Scott Moore acquires 21,700 common shares for $250,236.72

Reuters
·
Jun 16

Corvus Pharmaceuticals (CRVS) Is Up 7.3% After Promising Soquelitinib Data And Extended Cash Runway

Simply Wall St.
·
Jun 15

Corvus Pharmaceuticals shareholders elect directors at annual meeting

Reuters
·
Jun 13

Mizuho Securities Sticks to Their Buy Rating for Corvus Pharmaceuticals (CRVS)

TIPRANKS
·
Jun 12

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

BUZZ-Corvus rises as it invests in China partner to advance skin, asthma drug trials

Reuters
·
Jun 09

Corvus Pharmaceuticals - Invests $5 Mln in Angel Pharmaceuticals Financing

THOMSON REUTERS
·
Jun 09